Neumora Therapeutics, Inc. (NMRA) Earnings
|
Expand Research on NMRA
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +24.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/26  |
Q425 | N/A | -$0.47 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q425 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | -$0.35 | -$0.45 | +$0.10 | N/A | N/A | N/A |  | | Details | |
| 11/4/25 |
Q325 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/3/25 |
Q325 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 10/30/25 |
Q325 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 10/29/25 |
Q325 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/25 | Q225 | -$0.33 | -$0.45 | +$0.12 | N/A | N/A | N/A | | | Details |
